Dr. Eugene S. Bonapace Jr., MD

Dr. Bonapace practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Bonapace's NPI, 1053316505, was assigned on June 20, 2005. Dr. Bonapace graduated from New York University School of Medicine in 1993. Dr. Bonapace's New York license number on file is 197766.

Dr. Bonapace's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Bonapace's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Bonapace is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Bonapace to 2 more group practices and clinics, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bonapace practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Bonapace's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Bonapace is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Bonapace's licenses on file in 2 states: New York and Pennsylvania.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroduodenitis, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Bonapace treats.

CMS data shows 1,134 Medicare services from Dr. Bonapace across 11 procedure codes in 2024, for 506 Medicare patients. Medicare paid $148,210 for them.

CMS counts 506 Medicare patients who saw Dr. Bonapace in 2024. The largest group is 65 to 74, with 225 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bonapace's median patient age at 59, with 50% women.

In 2024, Dr. Bonapace wrote 1,838 Medicare Part D claims for 528 patients. 88% of them were for generic drugs. CMS names the drug for 1,596 of them, across 28 drugs with 11 or more claims each, at $207,446 in total drug cost. In 2023, CMS named 1,547 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Bonapace for performance year 2024, reported as part of a group. Dr. Bonapace accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bonapace as offering telehealth. CMS counts 120 procedures of colonoscopy by Dr. Bonapace, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Bonapace. The most frequent topics are Constipation, Dyspepsia and Gastrointestinal Transit. Dr. Bonapace has published most often in Dig Dis Sci.

CMS Open Payments shows 28 general payments to Dr. Bonapace from 13 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 65% of the total. QOL Medical, LLC paid the most, $400.

Dr. Bonapace graduated from New York University School of Medicine in 1993.

Dr. Bonapace is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.